Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germana Castelli

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Cancers|May 14, 2025
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|September 12, 2025
Outline of Iron Metabolism, with Emphasis on Erythroid CellsUgo Testa, Elvira Pelosi, Germana Castelli
Blood Cells, Molecules & Diseases|December 17, 2013
Endothelial progenitorsElvira Pelosi, Germana Castelli, Ugo Testa
Cancers|September 25, 2019
CD123 as a Therapeutic Target in the Treatment of Hematological MalignanciesUgo Testa, Elvira Pelosi, Germana Castelli
Annali Dell'Istituto Superiore Di Sanita|January 25, 2022
Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topicGermana Castelli, Elvira Pelosi, Ugo Testa
Medical Sciences (Basel, Switzerland)|October 4, 2018
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain TumorsUgo Testa, Germana Castelli, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Chimeric Antigen Receptor T Cells for the Treatment of Multiple MyelomaUgo Testa, Elvira Pelosi, Germana Castelli
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
TP53-Mutated Myelodysplasia and Acute Myeloid LeukemiaUgo Testa, Germana Castelli, Elvira Pelosi
Non-Coding RNA|April 17, 2018
miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor DevelopmentUgo Testa, Elvira Pelosi, Germana Castelli, et al.
Experimental Hematology|May 16, 2016
Oxidative stress and hypoxia in normal and leukemic stem cellsUgo Testa, Catherine Labbaye, Germana Castelli, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Cancers|May 14, 2025
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|September 12, 2025
Outline of Iron Metabolism, with Emphasis on Erythroid CellsUgo Testa, Elvira Pelosi, Germana Castelli
Blood Cells, Molecules & Diseases|December 17, 2013
Endothelial progenitorsElvira Pelosi, Germana Castelli, Ugo Testa
Cancers|September 25, 2019
CD123 as a Therapeutic Target in the Treatment of Hematological MalignanciesUgo Testa, Elvira Pelosi, Germana Castelli
Annali Dell'Istituto Superiore Di Sanita|January 25, 2022
Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topicGermana Castelli, Elvira Pelosi, Ugo Testa
Medical Sciences (Basel, Switzerland)|October 4, 2018
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain TumorsUgo Testa, Germana Castelli, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2024
Chimeric Antigen Receptor T Cells for the Treatment of Multiple MyelomaUgo Testa, Elvira Pelosi, Germana Castelli
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
TP53-Mutated Myelodysplasia and Acute Myeloid LeukemiaUgo Testa, Germana Castelli, Elvira Pelosi
Non-Coding RNA|April 17, 2018
miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor DevelopmentUgo Testa, Elvira Pelosi, Germana Castelli, et al.
Experimental Hematology|May 16, 2016
Oxidative stress and hypoxia in normal and leukemic stem cellsUgo Testa, Catherine Labbaye, Germana Castelli, et al.
Pageof 9